Seeing Eye to Eye on the Management of Neurotrophic Keratitis (CME Symposium)
To claim your credit for the symposium, please click Register/Take Course.
This educational activity is intended for ophthalmologists.
After completing this activity, participants will be better able to:
- Integrate corneal sensation assessments to cases that raise clinical suspicion of neurotrophic keratitis
- Apply clinical evidence to treatment selection for patients diagnosed with any stage of neurotrophic keratitis
Stephen C. Pflugfelder, MD
Kourtney H. Houser, MD
Sumitra Khandelwal, MD
MedEdicus adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CME activity, including faculty, planners, reviewers, or others, are required to disclose all financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been identified and mitigated by MedEdicus prior to the commencement of the activity.
Kourtney H. Houser, MD, is a consultant for Allergan, Bausch & Lomb Incorporated, Carl Zeiss Meditec, Inc, Dompé US, Inc, Sight Sciences, and Trukera; and is an advisory board member of Orasis Pharmaceuticals and Rayner.
Sumitra Khandelwal, MD, is a consultant for Allergan, Bausch & Lomb Incorporated, and Dompé US, Inc.
Stephen C. Pflugfelder, MD, is a consultant for Alcon, Dompé US, Inc, Hanall Biopharma, Kala Pharmaceuticals, KOWA Pharmaceuticals America, Inc, and Nicox; and is a contracted researcher for Dompé US, Inc.
This activity was peer reviewed. The peer reviewer has no relevant commercial relationships to disclose.
Planners, Managers, and Writers
MedEdicus planners, managers, and writers have no relevant commercial relationships to disclose.
MedEdicus LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Credit Designation Statement
MedEdicus LLC designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Disclosure of Commercial Support
This continuing medical education activity is supported through an educational grant from Dompé US, Inc.
This educational activity may include discussion of unlabeled and/or investigational uses of drugs and devices. Please refer to the official prescribing information for each drug or device discussed in this activity for approved dosing, indications, and warnings.
Provider Contact Information
For questions about this educational activity, please contact MedEdicus LLC at email@example.com.
The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of MedEdicus LLC or Dompé US, Inc.
©2023 MedEdicus LLC. 307a
- 1.50 AMA PRA Category 1 Credit™
- 1.50 Participation